Literature DB >> 2081493

Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.

I Stroehmann1, K H Giersch, H Zeidler, P Münzel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2081493     DOI: 10.2165/00003495-199000405-00012

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  1 in total

1.  [Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].

Authors:  E M Lemmel; I Stroehmann
Journal:  Fortschr Med       Date:  1988-04-20
  1 in total
  1 in total

1.  Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.

Authors:  H A Friedel; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.